Metrics Invests in New Stability Storage Facility
The company will be investing $3.5 million in a 15,00-square-foot facility in Greenville, North Carolina.
On Aug. 24, 2016, Metrics Contract Services announced that it will be investing $3.5 million in a 15,000-square-foot stability storage expansion that will triple its current capacity in Greenville, North Carolina. The $3.5-million stability storage facility is part of planned expansions at the Greenville campus, Metrics said in a press announcement. Mayne Pharma, the parent company of Metrics, is investing $80 million to expand facilities and equipment, including 10-plus new analytical labs and formulation development suites. Metrics will also introduce commercial-scale manufacturing capability including multi-particulate layering, bead-coating fluid bed technology, and significantly increased capacity to manufacture highly potent products.
Metrics’ expanded stability storage facility is being constructed with automated emergency power generation to ensure integrity of stored samples. System redundancies mean environmental controls remain in place in chambers should a primary conditioner go down. Metrics and Mayne Pharma have committed to hiring 110 new scientists, quality assurance specialists, and other technicians to support expanded operations, increasing their US workforce by more than a third.
Source: Metrics
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
